The studies have shown that genetic alterations in the RhoA pathway, including recurrent RHOA mutations and RhoGAP fusion along with the CDH1 mutations, are quite common in DGC but not in other variants of gastric cancer [36,76]. The gene discussed is RHOA; the disease is gastric cancer.